例如："lncRNA", "apoptosis", "WRKY"

[Gene diagnosis and treatment of hereditary hemorrhagic telangiectasia with epistaxis as its main symptom].

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jul;33(7):591-592. doi:10.13201/j.issn.1001-1781.2019.07.004
{{ author.authorName }}{{getOrganisationIndexOf(author)}} {{ author.authorName }}{{getOrganisationIndexOf(author)}}
{{ author.authorName }}{{getOrganisationIndexOf(author)}} {{ author.authorName }}{{getOrganisationIndexOf(author)}}
+ et al

[No authors listed]

Author information
  • {{index+1}} {{ organisation }}

摘要

Objective:The aim of this study is to investigate the gene diagnosis and the treatment of hereditary hemorrhagic telangiectasia (HHT) with epistaxis as the main symptom, and to analyze the mutation of ACVRL1 gene in the family. Method:Detailed pedigree investigation was carried out on the proband.Sixtynine genes related to coagulation disorder were sequenced and analyzed by high throughput sequencing for the father and son of the proband. Result:Four generations of the family consisted of 30 probands, including 11 patients. A pathogenic mutation ACVRL1_ex9 c.1313T > C (p.M438T) was detected in both patient and his father. Conclusion:Recurrent epistaxis is the main manifestation of hereditary hemorrhagic telangiectasia in this family. The mutation of ACVRL1 gene is the pathogenic gene of this family, which can be treated by surgery and medicine.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}

基因功能

  • {{$index+1}}.{{ gene }}

图表

原始数据

 保存测序数据
Sample name 		Organism Experiment title Sample type Library instrument Attributes
{{attr}}
{{ dataList.sampleTitle }} 		{{ dataList.organism }} {{ dataList.expermentTitle }} {{ dataList.sampleType }} {{ dataList.libraryInstrument }} {{ showAttributeName(index,attr,dataList.attributes) }}

文献解读

{{list.title }}

分析流程

© 2017 biocloud.net版权所有 ICP证：京10042835号